What is Prime Medicine's investments - amortized cost basis?

Prime Medicine (PRME) reported investments - amortized cost basis of $71.39M in Q1 2026.

How has Prime Medicine's investments - amortized cost basis changed year-over-year?

Prime Medicine's investments - amortized cost basis increased by 47.3% year-over-year, from $48.48M to $71.39M.

What is the long-term trend for Prime Medicine's investments - amortized cost basis?

Over 3 years (2022 to 2025), Prime Medicine's investments - amortized cost basis has grown at a 5.0% compound annual growth rate (CAGR), from $98.85M to $114.57M.

Prime Medicine PRME Investments - Amortized Cost Basis

Investments - Amortized Cost Basis at other companies

PrecigenPGEN

——

Viridian Therapeutics, Inc.VRDN

——

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's investments - amortized cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's investments - amortized cost basis?: Prime Medicine (PRME) reported investments - amortized cost basis of $71.39M in Q1 2026.
How has Prime Medicine's investments - amortized cost basis changed year-over-year?: Prime Medicine's investments - amortized cost basis increased by 47.3% year-over-year, from $48.48M to $71.39M.
What is the long-term trend for Prime Medicine's investments - amortized cost basis?: Over 3 years (2022 to 2025), Prime Medicine's investments - amortized cost basis has grown at a 5.0% compound annual growth rate (CAGR), from $98.85M to $114.57M.